BIRC5 and hepatocellular carcinoma: The K-M survival curves of the TMA cohort revealed that high expression of BIRC5 was associated with poor prognosis in HCC (Fig. 8L, PFI, p < 0.05; Fig. 8M, OS, p < 0.05).